best telehealth for semaglutide If weight loss is one of your big goals 2026, a medication may be part of your plan. Along with diet and exercise, options like and tirzepatide are helping more Semaglutide vs Tirzepatide isn't about

A small subset of patients (approximately 47% in clinical trials) discontinue semaglutide due to intolerable gastrointestinal side effects that do not adequately resolve

Alnylam and Inceptive have reached a strategic AI collaboration to accelerate the development of RNAi therapy On June 3, 2026, Alnylam Pharmaceuticals (NASDAQ: ALNY) and lnceptive Nucleics, a company dedicated to building life science foundation models, announced today that they have signed a strategic partnership agreement aimed at accelerating the development of innovative therapeutic drugs

Just personalized medicine that honors your biology, your experience, and your long-term wellbeing

However, one study has shown that people regain about two-thirds of the weight they lost after stopping the medication